Genolution Inc.
Genolution Inc. manufactures and sells IVD medical instruments in South Korea and internationally. Its products are primarily focused on molecular diagnostics, ribonucleic acid interference (RNAi) services, and double-stranded RNA (dsRNA) synthesis technology. The company offers Nextractor NX-Duo, Nextractor NX-32N/45N, Nextractor NX-Jr, Nextractor NX-24SA, NGS library preparation equipment, DNA/… Read more
Genolution Inc. (225220) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.013x
Based on the latest financial reports, Genolution Inc. (225220) has a cash flow conversion efficiency ratio of -0.013x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-927.21 Million) by net assets (₩73.39 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Genolution Inc. - Cash Flow Conversion Efficiency Trend (2016–2024)
This chart illustrates how Genolution Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Genolution Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Genolution Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Alrov Properties & Lodgings Ltd
TA:ALRPR
|
0.006x |
|
Inoue Rubber (Thailand) Public Company Limited
BK:IRC
|
0.034x |
|
OUTBRAIN INC. DL-001
F:852
|
N/A |
|
Jervois Global Ltd
AU:JRV
|
-0.038x |
|
BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877-
F:BLH
|
0.003x |
|
UMeWorld Limited
PINK:UMEWF
|
0.063x |
|
Mont Royal Resources Ltd
AU:MRZ
|
-0.008x |
|
ADVICENNE (PROM.) EO-20
F:3MM
|
N/A |
Annual Cash Flow Conversion Efficiency for Genolution Inc. (2016–2024)
The table below shows the annual cash flow conversion efficiency of Genolution Inc. from 2016 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩80.29 Billion | ₩-1.43 Billion | -0.018x | -37.43% |
| 2023-12-31 | ₩87.45 Billion | ₩-1.14 Billion | -0.013x | -109.07% |
| 2022-12-31 | ₩94.70 Billion | ₩13.55 Billion | 0.143x | -54.29% |
| 2021-12-31 | ₩82.20 Billion | ₩25.73 Billion | 0.313x | -58.26% |
| 2020-12-31 | ₩61.29 Billion | ₩45.97 Billion | 0.750x | +2556.06% |
| 2019-12-31 | ₩2.64 Billion | ₩-80.58 Million | -0.031x | -160.85% |
| 2018-12-31 | ₩2.94 Billion | ₩147.49 Million | 0.050x | -72.00% |
| 2017-12-31 | ₩4.00 Billion | ₩717.13 Million | 0.179x | +2372.91% |
| 2016-12-31 | ₩3.42 Billion | ₩-27.00 Million | -0.008x | -- |